Close

Alnylam to Webcast Presentation at Chardan Virtual 5th Annual Genetic Medicines Conference Sep 28, 2021 04:00PM
Alnylam to Webcast Presentation at Chardan Virtual 4th Annual Genetic Medicines Conference Sep 28, 2020 04:00PM
Alnylam Pharmaceuticals (ALNY) PT Raised to $190 at Chardan Capital Markets Dec 19, 2019 07:48AM
Alnylam Pharmaceuticals (ALNY) PT Raised to $175 at Chardan Capital Markets Jan 19, 2018 07:41AM
Alnylam Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares Nov 16, 2017 04:00PM


Nov 14, 2017 05:48AM Alnylam Pharma (ALNY) Prices 5.6M Share Common Offering at $125/Sh
Nov 13, 2017 08:02PM Alnylam Pharmaceuticals Prices Public Offering of Common Stock
Aug 29, 2017 03:20AM Chardan Capital Markets Downgrades Intellia Therapeutics (NTLA) to Neutral
Aug 10, 2017 07:27AM Alnylam Pharma (ALNY): Cutting PT to $124 - Chardan
Jul 7, 2017 10:56AM Alnylam Pharmaceuticals (ALNY) PT Raised to $131 at Chardan Capital Markets
May 15, 2017 09:37AM Alnylam Pharmaceuticals (ALNY) PT Raised to $110 at Chardan Capital Markets
May 5, 2017 10:07AM Alnylam Pharmaceuticals (ALNY) PT Trimmed to $95 at Chardan Capital Markets
Jan 9, 2017 06:56AM Alnylam Pharmaceuticals (ALNY) PT Raised 41% at Chardan Capital Markets to $97
Dec 5, 2016 08:30AM Chardan Capital Markets Positive on Alnylam (ALNY) as ASH Data Reinforces Potential for RNAi Across Hemophilia and AIP
Nov 30, 2016 06:33AM Alnylam Pharmaceuticals (ALNY) PT Raised to $89 at Chardan Capital Markets Following Arrowhead's RNAi Program Discontinuations
Oct 6, 2016 07:39AM Alnylam Pharmaceuticals (ALNY) PT Cut to $77 at Chardan
Apr 5, 2016 07:35AM Chardan Capital Markets Starts Alnylam Pharmaceuticals (ALNY) at Buy
Nov 11, 2015 12:35PM Medicines Co. (MDCO), Alnylam' (ALNY) ALN-PCSsc Data Affirm Potential bi-Annual Dose Regimen - Chardan Capital
Aug 31, 2015 08:12AM Chardan Trims PT on Esperion (ESPR) to $36 as Negatives Continue Increasing